Published in Circulation on December 01, 1995
Debate: Do all patients with heart failure require automatic implantable defibrillators for the prevention of sudden death? Curr Control Trials Cardiovasc Med (2000) 0.81
Implantable cardioverter-defibrillators in arrhythmias: a rapid and systematic review of effectiveness. Heart (2002) 0.81
Perspectives: does amiodarone increase non-sudden deaths? If so, why? J Interv Card Electrophysiol (2000) 0.77
Influence of the implantable cardioverter-defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation. Circulation (1997) 0.75
Influence of implantable cardioverter-defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation. Circulation (1997) 0.75
ICD use as a bridge to cardiac transplantation. Circulation (1996) 0.75
Role of orthotopic heart transplantation in the management of patients with recurrent ventricular tachyarrhythmias following myocardial infarction. Heart (1998) 0.75
Advances in cardiology: the complementary roles of concept and technology. J Interv Card Electrophysiol (1997) 0.75
[Not Available]. Herzschrittmacherther Elektrophysiol (2000) 0.75
Apoptosis in myocytes in end-stage heart failure. N Engl J Med (1996) 6.19
The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest (1996) 5.29
Risk factors for pancreatic cellular injury after cardiopulmonary bypass. N Engl J Med (1991) 4.66
Cardiac surgery report cards: comprehensive review and statistical critique. Ann Thorac Surg (2001) 4.26
Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med (1994) 4.00
The relationship between managed care insurance and use of lower-mortality hospitals for CABG surgery. JAMA (2000) 3.75
Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a. Circulation (1999) 3.19
Fish consumption and risk of sudden cardiac death. JAMA (1998) 3.06
Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol (1995) 2.84
Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation (1994) 2.77
Malignant tumours of the heart: a review of tumour type, diagnosis and therapy. Clin Oncol (R Coll Radiol) (2007) 2.67
Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation (1997) 2.65
Proteins of the human erythrocyte membrane as modified by pronase. J Mol Biol (1971) 2.51
Adverse reactions during treatment with amiodarone hydrochloride. Br Med J (Clin Res Ed) (1983) 2.43
Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci U S A (1999) 2.42
Intraaortic balloon pumping for cardiac support: trends in practice and outcome, 1968 to 1995. J Thorac Cardiovasc Surg (1997) 2.27
Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group. Circulation (1990) 2.22
The QT interval. Prog Cardiovasc Dis (2001) 2.22
Insights from three-dimensional echocardiography into the mechanism of functional mitral regurgitation: direct in vivo demonstration of altered leaflet tethering geometry. Circulation (1997) 2.22
Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest. Circulation (1993) 2.20
Modulation of ventricular function through gene transfer in vivo. Proc Natl Acad Sci U S A (1998) 2.19
Subclavian crush syndrome complicating transvenous cardioverter defibrillator systems. Pacing Clin Electrophysiol (1995) 2.14
Brief report: recognition of acute myocarditis masquerading as acute myocardial infarction. N Engl J Med (1993) 2.14
Heart failure in outpatients: a randomized trial of digoxin versus placebo. N Engl J Med (1982) 2.09
Active myocarditis in the spectrum of acute dilated cardiomyopathies. Clinical features, histologic correlates, and clinical outcome. N Engl J Med (1985) 1.99
Classification of mouse VK groups based on the partial amino acid sequence to the first invariant tryptophan: impact of 14 new sequences from IgG myeloma proteins. Mol Immunol (1982) 1.93
Electrical alternans and cardiac electrical instability. Circulation (1988) 1.86
Giant cell versus lymphocytic myocarditis. A comparison of their clinical features and long-term outcomes. Circulation (1991) 1.85
Socioeconomic status as an independent risk factor for hospital readmission for heart failure. Am J Cardiol (2001) 1.81
Surgical coronary revascularization in survivors of prehospital cardiac arrest: its effect on inducible ventricular arrhythmias and long-term survival. J Am Coll Cardiol (1990) 1.73
The role of percutaneous aortic balloon valvuloplasty in patients with cardiogenic shock and critical aortic stenosis. J Am Coll Cardiol (1994) 1.72
Prediction of successful outcome in 130 patients undergoing percutaneous balloon mitral valvotomy. Circulation (1990) 1.71
An occidental case of cardiomyopathy and selenium deficiency. N Engl J Med (1981) 1.69
Out-of-hospital cardiac arrest. Use of electrophysiologic testing in the prediction of long-term outcome. N Engl J Med (1988) 1.68
Echocardiographic assessment of patients with infectious endocarditis: prediction of risk for complications. J Am Coll Cardiol (1991) 1.67
Reconsideration of echocardiographic standards for mitral valve prolapse: lack of association between leaflet displacement isolated to the apical four chamber view and independent echocardiographic evidence of abnormality. J Am Coll Cardiol (1988) 1.65
Quality of care and hospital readmission in congestive heart failure: an explicit review process. J Card Fail (2001) 1.63
Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med (1989) 1.62
Diagnostic accuracy of antimyosin scintigraphy in suspected myocarditis. J Nucl Cardiol (1997) 1.58
Sex differences in cardiac arrest survivors. Circulation (1996) 1.57
Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy. Circulation (2001) 1.56
Effect of vesnarinone on cardiac function in patients with severe congestive heart failure. Am Heart J (1998) 1.52
Risk of reoperative valve replacement for failed mitral and aortic bioprostheses. Ann Thorac Surg (1998) 1.52
Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris. J Am Coll Cardiol (1993) 1.51
Mechanism of ischemic mitral regurgitation with segmental left ventricular dysfunction: three-dimensional echocardiographic studies in models of acute and chronic progressive regurgitation. J Am Coll Cardiol (2001) 1.51
Sudden cardiac death: management of high-risk patients. Ann Intern Med (1991) 1.49
Inhaled nitric oxide improves exercise capacity in patients with severe heart failure and right ventricular dysfunction. Am J Cardiol (1998) 1.47
Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database. J Heart Lung Transplant (1998) 1.46
Mutations in the long QT gene, KCNQ1, are an uncommon cause of atrial fibrillation. Heart (2004) 1.45
Warm heart surgery in patients with cold autoimmune disorders. Ann Thorac Surg (1993) 1.45
Gamma imaging with negatively charge-modified monoclonal antibody: modification with synthetic polymers. J Nucl Med (1991) 1.45
Inotropic effect of nicardipine in patients with heart failure: assessment by left ventricular end-systolic pressure-volume analysis. J Am Coll Cardiol (1989) 1.44
Rapid cooling contracture with cold cardioplegia. Ann Thorac Surg (1997) 1.43
Quantitation of acute myocardial infarct size by nuclear magnetic resonance imaging. J Am Coll Cardiol (1990) 1.43
Inspiratory muscle training in patients with chronic heart failure awaiting cardiac transplantation: results of a pilot clinical trial. Phys Ther (1997) 1.43
The pathophysiology of failure in acute right ventricular hypertension: hemodynamic and biochemical correlations. Circulation (1981) 1.43
Papillary muscle displacement causes systolic anterior motion of the mitral valve. Experimental validation and insights into the mechanism of subaortic obstruction. Circulation (1995) 1.42
Potential impact of pulmonary artery catheter placement on short-term management decisions in the medical intensive care unit. Am Heart J (1993) 1.40
Immediate reproducibility of electrically induced sustained monomorphic ventricular tachycardia before and during antiarrhythmic therapy. J Am Coll Cardiol (1991) 1.39
Ischemic intervals during warm blood cardioplegia in the canine heart evaluated by phosphorus 31-magnetic resonance spectroscopy. J Thorac Cardiovasc Surg (1997) 1.39
Effect of recombinant human erythropoietin on transfusion risk in coronary bypass patients. Ann Thorac Surg (1997) 1.39
Relationship between pulmonary artery diameter at computed tomography and pulmonary artery pressures at right-sided heart catheterization. Massachusetts General Hospital Lung Transplantation Program. Acad Radiol (1997) 1.39
Effects of disopyramide on left ventricular diastolic function in hypertrophic cardiomyopathy. Am J Cardiol (1994) 1.38
The effects of calcium and magnesium in hyperkalemic cardioplegic solutions on myocardial preservation. J Thorac Cardiovasc Surg (1989) 1.38
Immunologic basis of transplant-associated arteriosclerosis. Proc Natl Acad Sci U S A (1996) 1.37
Out-of-hospital cardiac arrest: electrophysiologic observations and selection of long-term antiarrhythmic therapy. N Engl J Med (1980) 1.36
Socioeconomic status is an important determinant of the use of invasive procedures after acute myocardial infarction in New York State. Circulation (2000) 1.34
Mitral valve reconstruction versus replacement for degenerative or ischemic mitral regurgitation. Ann Thorac Surg (1994) 1.31
Limitations and late complications of third-generation automatic cardioverter-defibrillators. Circulation (1995) 1.26
Inhaled nitric oxide in congenital heart disease. Circulation (1993) 1.26
Amiodarone keratopathy: drug-induced lipid storage disease. Arch Ophthalmol (1981) 1.26